[ad_1]
First Germany, then Italy and therefore also the France and the Spain. A few minutes from each other, some of the main European countries have decided to suspend the administration of the vaccine produced by Astrazeneca. The stop, as far as we know, was agreed at European level waiting for the meetings of theMother, that Thursday should express a new opinion in light of the vaccination surveillance of these weeks.
In Berlin, German media reported, the federal government relied on a recommendation from the Paul Ehrlich Institute, a spokesman for the Ministry of Health, that you deem necessary “Thorough investigation” following the reports of vaccination-related thrombosis cases in several Member States, including Germany itself. In France, the announcement was made directly by the president Emmanuel Macron. In recent days, Astrazeneca injections had been suspended in Denmark, Norway, Iceland and continue on Bulgaria, Romania, Ireland, Austria me Netherlands, precisely in view of the new EMA investigations.
the Security Committee The EMA will further review the information on thromboembolism “tomorrow, Tuesday, and has convened one Extraordinary meeting On Thursday March 18 to conclude on what was collected and on any additional action that may be necessary “, announces the EU Agency in a note in which it explains that” it is working closely with the company, blood diseases and with other health authorities “, including the UK regulatory body, Mhra, for “his experience with approximately 11 million administered doses of the vaccine.”
The investigation, adds the EMA, “continued over the weekend and in the next few days arigorous analysis of all data related to thromboembolic events “reported. Experts, concludes the EU Agency, are examining in detail” all available data and clinical circumstances “ on “specific cases to determine if the vaccine could have contributed or if it is probable that the fact was due to other causes “.
Although the investigation is ongoing, the European Medicines Agency “currently continues to believe that I Benefits of the AstraZeneca vaccine in the prevention of Covid-19, with the risk of hospitalization and death associated “with the disease”, outweigh the risks of side effects” possibly related to the vaccine itself. “The Covid-19 pandemic is a global crisis with a Impact on healthsocially and economically devastating – underlines the EU regulatory body – and continues to represent a heavy load by and Systems of health of the European Union. “Anti-Covid vaccines, continues the EMA,” help protect people from contracting the disease, in particular the Health workers and vulnerable categories such as the elderly or chronically ill ”.
“We know the scope of this decision that was not made lightly. But it is one factual decision and not politics, ”said the German health minister. Jens spahn, reiterating that the suspension is for “Pure caution”. Then he emphasized that “to maintain the trust in the vaccine we have to give ours experts the moment to verify the new cases “and” clear the field of any risk, “he continued. 7 cases of cerebral venous thrombosis over 1.6 million vaccines administered in Germany. “It is a”very low risk. But if there was a link to the vaccine, it would be above average“.
Fears related to suspected cases of thrombosis are also shared in France. “Based on the recommendation of our Minister of Health,” explained Macron, “the decision was made to suspend the vaccination with AstraZeneca as a precautionary measure, hoping to resume it quickly if the opinion of the EMA allows it. The stop, he added, for now is set to “Tomorrow in the afternoonSources cited by the Ansa report, however, that EU experts may not reach a result tomorrow, but the definitive answers are expected in the week. A note from the Italian Ministry of Health made it clear that there was coordination at the European level. “During the day Hope has had conversations with the health ministers of Germany, France and Spain“And in fact, Madrid late in the afternoon also adopted the same line after the emergency meeting the Interterritorial Health Council.
Germany, France, Spain and Italy are therefore the first major countries to impose a stop, having initially decided to continue the campaign. He was among the first to ask the health authorities to clarify Markus Soeder, leader of the CSU and president of Bavaria. Lack of clarity could lead to a “public acceptance problem” of the vaccine: “Is the vaccine good or not? Now we need a statement that this vaccine is effective And it works, ”Soeder said. The drug developed by the university of Oxford, the UK government reiterated, is “Safe and effective”, according to the data of the administration in progress in UK, where beyond 11 million people they already received the serum and no “increased thrombosis” was observed.
A push to continue vaccination also came from the World Health Organization: “Unfortunately, people die of thrombosis every day, the key is whether this has any link with the vaccine. At the moment we have not found that there is one report between the vaccine and the detected cases of thrombosis. In fact, thrombosis rates among vaccinated people are even lower those of the population as a whole. None the drug is 100% safe, but you have to take into account the advantages of vaccinating the population, “he said. Soumya Swaminathan, WHO Chief Scientist, in instructions from Geneva.
[ad_2]
